Eyebright Medical has established its Asia-Pacific headquarters in Singapore, with the regional market becoming increasingly important for the group's growth | Lianhe Zaobao

The German medical technology company Eyebright Medical, known for its electrosurgery technology, has established its Asia-Pacific headquarters in Singapore. Eyebright Medical has been in operation for 175 years this year, and held an opening ceremony for its Asia-Pacific headquarters in Singapore on Monday (March 30), celebrating its 175th anniversary. In a statement, the company said: "The Asia-Pacific region is becoming increasingly important to Eyebright Medical's global growth strategy, and this anniversary event in Singapore is a highlight of the company's global 175th anniversary celebrations. Singapore now serves as Eyebright Medical's Asia-Pacific regional headquarters, and this event underscores Singapore's significance as a center for innovation, clinical collaboration, and regional leadership." The invention of electrosurgery technology has a history of over 100 years, and such devices are now widely used in surgical procedures to help prevent blood loss during operations. Eyebright Medical revealed that it has been expanding its business in Singapore for over 20 years, establishing a subsidiary in Singapore 14 years ago, growing from a small office to an important strategic center for the group today. The Singapore office was officially upgraded to the Asia-Pacific headquarters in January this year, consolidating customer service, regional revenue management, marketing, sales, maintenance operations, and digital R&D functions in one location. "This milestone marks one of the most significant expansion actions for Eyebright Medical's global business this year." Further Reading American medical packaging company Nelipak establishes new technology R&D center to expedite medical product market entry Medical AI company Heidi establishes regional headquarters locally, plans to invest up to tens of millions This Asia-Pacific headquarters is expected to create new jobs and deepen local capabilities in various areas, including digital innovation, maintenance engineering, regional training, business operations, and marketing development. It will expand the digital R&D department of the Singapore office, creating new professional positions, accelerating the development of surgical application software, process integration, and the development of digital solutions Singapore is also the Asia-Pacific clinical research hub for Eyebright Medical, led by a locally based clinical research manager who oversees regional clinical research activities and manages cross-border clinical research teams. The company's announcement stated that Eyebright Medical plans to continue investing in Singapore in 2026 and beyond, committing to nurturing local talent and strengthening Singapore as a world-class surgical technology innovation center. Fritz Maier, Vice President of Eyebright Medical Asia-Pacific, said, "Singapore has been our strategic base in the Asia-Pacific for many years because it provides world-class research partners, a highly skilled clinical community, and a forward-looking environment that encourages the development, testing, and scaling of new solutions." He stated that as the group deepens local collaboration, Singapore continues to be an ideal base for accelerating their growth and contributing to advancements in regional surgery